ABHD5 Antibodies

Santa Cruz Biotechnology provides a broad selection of ABHD5 monoclonal antibodies for research focused on understanding ABHD5 protein function. ABHD5 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ABHD5, also known as Abhydrolase Domain Containing 5, plays a crucial role in lipid metabolism and is involved in the regulation of lipid droplet dynamics. ABHD5 acts as a co-activator for the enzyme adipose triglyceride lipase (ATGL), facilitating the breakdown of stored triglycerides into free fatty acids. Understanding ABHD5 function is essential for elucidating metabolic disorders and developing therapeutic strategies. ABHD5 monoclonal antibodies enable detailed investigation of lipid metabolism pathways in various experimental conditions. Researchers can effectively track ABHD5 expression and localization across different cellular compartments. Advanced visualization techniques using ABHD5 monoclonal antibodies allow for precise mapping of protein interactions and metabolic processes. Santa Cruz Biotechnology monoclonal antibodies for ABHD5 support researchers worldwide in advancing our understanding of metabolic regulation and disease mechanisms.